The basic and clinical research for depression has found that NLRP3 inflammasomes are in an activated state, and antidepressant treatment can inhibit the activity (Xue et al., 2015) of NLRP3 inflammasomes. The gene discussed is NLRP3; the disease is depressive symptom measurement.